Idorsia Financials
| IDIA Stock | CHF 0.77 0.02 2.67% |
Idorsia |
Understanding current and past Idorsia Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Idorsia's financial statements are interrelated, with each one affecting the others. For example, an increase in Idorsia's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Idorsia's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Idorsia. Check Idorsia's Beneish M Score to see the likelihood of Idorsia's management manipulating its earnings.
Idorsia Stock Summary
Idorsia competes with VAT Group, Lonza Group, Basilea Pharmaceutica, Straumann Holding, and Santhera Pharmaceuticals. Idorsia Ltd, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs. The company was incorporated in 2017 and is headquartered in Allschwil, Switzerland. Idorsia Ltd is traded on Switzerland Exchange in Switzerland.| Instrument | Switzerland Stock View All |
| Exchange | SIX Swiss Exchange |
| ISIN | CH0363463438 |
| Business Address | Hegenheimermattweg 91, Allschwil, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.idorsia.com |
| Phone | 41 58 844 10 10 |
| Currency | CHF - Swiss Franc |
You should never invest in Idorsia without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Idorsia Stock, because this is throwing your money away. Analyzing the key information contained in Idorsia's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Idorsia Key Financial Ratios
There are many critical financial ratios that Idorsia's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Idorsia reports annually and quarterly.| Return On Equity | -64.61 | |||
| Return On Asset | -0.42 | |||
| Target Price | 16.53 | |||
| Number Of Employees | 11 | |||
| Beta | 0.57 |
Idorsia Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Idorsia's current stock value. Our valuation model uses many indicators to compare Idorsia value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Idorsia competition to find correlations between indicators driving Idorsia's intrinsic value. More Info.Idorsia is rated second overall in return on equity category among its peers. It is currently regarded as number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Idorsia's earnings, one of the primary drivers of an investment's value.Idorsia Systematic Risk
Idorsia's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Idorsia volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Idorsia correlated with the market. If Beta is less than 0 Idorsia generally moves in the opposite direction as compared to the market. If Idorsia Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Idorsia is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Idorsia is generally in the same direction as the market. If Beta > 1 Idorsia moves generally in the same direction as, but more than the movement of the benchmark.
Idorsia November 23, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Idorsia help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Idorsia. We use our internally-developed statistical techniques to arrive at the intrinsic value of Idorsia based on widely used predictive technical indicators. In general, we focus on analyzing Idorsia Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Idorsia's daily price indicators and compare them against related drivers.
| Information Ratio | (0.37) | |||
| Maximum Drawdown | 26.69 | |||
| Value At Risk | (8.29) | |||
| Potential Upside | 5.31 |
Additional Tools for Idorsia Stock Analysis
When running Idorsia's price analysis, check to measure Idorsia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Idorsia is operating at the current time. Most of Idorsia's value examination focuses on studying past and present price action to predict the probability of Idorsia's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Idorsia's price. Additionally, you may evaluate how the addition of Idorsia to your portfolios can decrease your overall portfolio volatility.